Oura ring doesn’t accurately measure sleep quality, lawsuit says

Class Action Targets Oura Ring’s Sleep-Scoring Claims

Cybersecarmor.com – A federal lawsuit filed on August 20 in U.S. District Court in California accuses the smart-ring maker Oura of overstating what its wearable can actually detect about a wearer’s nightly rest. The complaint, brought as a class action, contends that the company’s marketing paints a picture of near-clinical precision that the hardware simply cannot deliver — a gap the plaintiffs say misleads millions of consumers who rely on a single overnight number to gauge their health.

The Market at Stake

The suit positions Oura at the heart of what it describes as a nearly $7 billion sleep-tracking industry in the United States. Sleep has surged into the top tier of consumer health priorities, and wearable devices — from Oura’s ring to WHOOP bracelets and Apple Watches — have become the primary tools Americans use to quantify how long and how well they slept. The complaint alleges that Oura, headquartered in San Francisco, has captured outsized influence in that space, selling close to three million rings in 2025 alone and generating more than $1 billion in annual revenue.

For a consumer who has spent years exhausted, anxious, and cycling through poor nights, the company’s pitch carries real emotional weight. The lawsuit quotes its own framing of that dynamic:

“Every morning, we reach for our phone before we open our eyes — not to check messages, but to check how we slept. We see a number from 0 to 100, the total sleep score telling us how well we slept. The next set of measurements follow: the time spent in deep sleep, in REM sleep and in light sleep; sleep efficiency, time in bed, restfulness, awake time; and other similar markers. For a consumer who has spent years exhausted, anxious and struggling with sleep, that number feels like an answer.”

What the Ring Actually Measures

At its core, the complaint argues, the Oura ring does not read brain activity. It sits on a finger and records heart rate, skin temperature, and body movement. An algorithm then converts those peripheral signals into an estimate of sleep architecture. Shireen Clarkson, co-founder of the Clarkson Law Firm that filed the suit, put the technical gap in blunt terms:

“What the ring does is, it sits on your finger, and it measures heart rate and skin temperature and body movement, and the algorithm spits out an estimate based on those signals about what your sleep stages are. People are relying on this information for their health, and I think that’s where the danger lies.”

Clarkson said Oura told customers its ring could classify sleep stages with 95 percent accuracy. Her firm’s position is that real-world accuracy hovers closer to fifty percent — essentially a coin flip — making the marketing claim materially misleading.

Oura’s Response

The company pushed back quickly. In a statement issued in response to the filing, Oura said it “disputes the allegations in this complaint and intends to defend against them.” The firm elaborated that its ring “estimates sleep stages using multiple physiological signals, including heart rate, heart rate variability, movement, breathing patterns, and temperature,” and pointed to “well-documented, peer-reviewed independent scientific evidence” linking sleep stages to measurable physiological changes.

Oura acknowledged the ring is not “a substitute for a clinical sleep study” but argued its methodology “has been validated and compared favorably in multiple studies” against laboratory polysomnography. The company added that “multiple third-party, independent studies support our claims of accuracy, and we have transparently reported on the mechanisms and measures that inform Oura’s sleep staging.”

The Plaintiff and the Broader Debate

The suit was brought on behalf of Madison Surber, a California resident who purchased an Oura ring for $513.68 in 2025 after being drawn in by the company’s promotional language. The complaint characterizes that language as a promise of continuous, deeply personal health monitoring:

“Comfortably wear Oura Ring all day and night to collect deeply personal health metrics and insights… Your finger provides the most accurate reading with 50+ health metrics that directly impact how you feel.”

The lawsuit also notes that Oura’s own product literature concedes the ring cannot replicate a laboratory sleep study — but buries that caveat deep within technical documentation rather than surfacing it in marketing copy.

The case lands amid a widening conversation about what wearable health trackers can and cannot do. Peer-reviewed research has documented that quantified sleep scores can heighten anxiety in some users who over-index on nightly numbers, while other wearers report that the data nudges them toward healthier bedtime routines. The Oura suit does not dispute that wearables can inform habits; it disputes the precision implied by the company’s accuracy claims and the weight consumers place on a single composite score.

What Comes Next

The complaint seeks to halt what it calls unlawful marketing practices and to recover damages for consumers who purchased rings under the disputed representations. If the court allows the class to proceed, the outcome could shape how every wearable-health company frames its accuracy language — from rings to wristbands to earbuds — and how regulators evaluate the boundary between useful estimation and overpromised measurement in consumer health technology.